Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 6/20 | 0.50 |
| ▸ | ACE | P12821 | 3/20 | 0.50 |
| ▸ | CPA1 | P15085 | 2/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.50 |
| ▸ | CTSB | P07858 | 1/20 | 0.49 |
| ▸ | GNPAT | O15228 | 1/20 | 0.49 |
| ▸ | MMP2 | P08253 | 1/20 | 0.49 |
| ▸ | MMP7 | P09237 | 1/20 | 0.49 |
| ▸ | MMP9 | P14780 | 1/20 | 0.49 |
| ▸ | MMP12 | P39900 | 1/20 | 0.49 |
| ▸ | MMP13 | P45452 | 1/20 | 0.49 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.48 |
| ▸ | CTSC | P53634 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27852467 | 0.94 | MME (0.53) | MMEACECPA1ACE2MMP2 | |
| SCHEMBL27852469 | 0.94 | MME (0.53) | MMEACECPA1ACE2MMP2 | |
| SCHEMBL30054155 | 0.93 | MME (0.56) | MMEACECPA1ACE2OPRM1 | |
| SCHEMBL29784904 | 0.92 | BACE1 (0.47) | MMEACEOPRM1OPRD1CTSB | |
| SCHEMBL30055181 | 0.92 | MME (0.49) | MMEACECPA1ACE2OPRM1 | |
| SCHEMBL29658166 | 0.91 | MME (0.60) | MMEOPRM1OPRD1CTSBPSMB5 | |
| SCHEMBL31257978 | 0.91 | OPRD1 (0.57) | MMEACEOPRM1OPRD1 | |
| SCHEMBL8068326 | 0.89 | MME (0.61) | MMEACECPA1ACE2GNPAT | |
| SCHEMBL8068319 | 0.89 | MME (0.61) | MMEACECPA1ACE2GNPAT | |
| SCHEMBL31419815 | 0.89 | KISS1R (0.48) | MMEOPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113150146-B | IL-4R alpha antibodies and uses thereof | 北京凯因科技股份有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-114478789-A | anti-PD-L1 and OX40 bispecific antibodies and uses thereof | 安徽安科生物工程（集团）股份有限公司 | 2022-05-13 | — | — | CN | disclosed |